Jane Street’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Jane Street’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-72,100	Closed	-$1.45M	–	11155
2021 Q3	$1.45M	Sell	72,100 -48,500	-40%	-$1.34M	﹤0.01%	5136
2021 Q2	$4.5M	Buy	120,600 +60,200	+100%	+$1.85M	﹤0.01%	2831
2021 Q1	$1.54M	Buy	+60,400	New	+$1.54M	﹤0.01%	4530
2020 Q3	–	Sell	-32,600	Closed	-$828K	–	8268
2020 Q2	$828K	Buy	+32,600	New	+$702K	﹤0.01%	4341

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Jane Street's DRNA Position: Q4 2021 in Review

Jane Street sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 24,368 shares — an estimated $491K sold.

Jane Street first reported a position in DRNA in Q2 2016 and held it in 11 quarters. The position peaked at $3.75M in Q3 2020. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Jane Street reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Jane Street sold 24,368 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $491K.
Jane Street first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2016 and held it in 11 quarters.
Jane Street's Dicerna Pharmaceuticals, Inc. position peaked at $3.75M in Q3 2020.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Jane Street's 13F filing for Q4 2021, filed 15 Feb 2022.